SandboxAlonso: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 69: | Line 69: | ||
===Local or regional recurrence=== | ===Local or regional recurrence=== | ||
{{familytree/start}} | |||
{{familytree | | | | | | | | | A01 | | | | | | | | | | A01=What is the site of the recurrence?}} | |||
{{familytree | |,|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|.| | |}} | |||
{{familytree | B01 | | B02 | | B03 | | B04 | | B05 | | | B01=Bronchial obstruction|B02=Mediastinal lymph node|B03=Superior vena cava obstruction|B04=Severe hemoptisis|B05=Resectable tumor}} | |||
{{familytree/end}} | |||
===Systemic metastasis=== | ===Systemic metastasis=== |
Revision as of 16:57, 20 June 2014
Stage IV
Is pleural or pericardial effusion present (suggestive of M1a) or are findings suggestive of systemic metastasis (M1b) present? | |||||||||||||||||||||||||||||||||||||||||||||
M1a | M1b | ||||||||||||||||||||||||||||||||||||||||||||
Perform the following tests:
| Perform the following tests:
| ||||||||||||||||||||||||||||||||||||||||||||
Is the liquid extracted positive for malignant cells? | Are findings suggestive of adrenal metastasis or brain metastasis? | ||||||||||||||||||||||||||||||||||||||||||||
Yes | No | Adrenal | Brain | ||||||||||||||||||||||||||||||||||||||||||
Local therapy
PLUS | Perform a needle aspiration biopsy for metastasis confirmation | Surgical resection + adjuvant radiation therapy Radiation therapy alone:
PLUS | |||||||||||||||||||||||||||||||||||||||||||
What is the TN stage of the lung tumor? | |||||||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||||||
| Administer therapy for metastatic disease in case of not curable lung lesions (click here for the treatment of local and systemic metastasis and neoplastic recurrence) | ||||||||||||||||||||||||||||||||||||||||||||
Follow-up
Controls of history + physical exam and chest CT with or without contrast every 6-12 months (first 2 years), then annual controls | |||||||||||||||||||||||||
Is there evidence of local or regional recurrence OR systemic metastasis? | |||||||||||||||||||||||||
Local or regional recurrence | Systemic metastasis | ||||||||||||||||||||||||
Local or regional recurrence
What is the site of the recurrence? | |||||||||||||||||||||||||||||||||||||||||
Bronchial obstruction | Mediastinal lymph node | Superior vena cava obstruction | Severe hemoptisis | Resectable tumor | |||||||||||||||||||||||||||||||||||||
Systemic metastasis
Metastatic disease
What the specific subtype according to the specific histological characteristics of the tumor? | |||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | ||||||||||||||||||||||||||||||||||||||
Perform specific EGFR and ALK mutation testing: What is the specific mutation? | Is the patient smoker or former smoker? | ||||||||||||||||||||||||||||||||||||||
Sensitizing EGFR mutation | ALK mutation | Negative EGFR and ALK | Click here for the squamous cell carcinoma specific treatment | ||||||||||||||||||||||||||||||||||||
Click here for the sensitizing EGFR mutation specific treatment | Click here for the specific therapy for the ALK mutation specific treatment | Click here for the treatment of negative sensitizing EGFR and ALK mutation metastatic disease | |||||||||||||||||||||||||||||||||||||